Rajesh C. Shrotriya MD - 15 Jul 2022 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Director
Signature
/s/ Rajesh Shrotriya
Issuer symbol
GTBP
Transactions as of
15 Jul 2022
Net transactions value
$0
Form type
4
Filing time
19 Jul 2022, 21:46:37 UTC
Previous filing
26 May 2022
Next filing
01 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +50,000 $0.000000 50,000 15 Jul 2022 Common Stock 50,000 $2.48 Direct
transaction GTBP Option to purchase Common Stock Award $0 +50,000 $0.000000 50,000 15 Jul 2022 Common Stock 50,000 $2.48 Direct F1
transaction GTBP Option to purchase Common Stock Award $0 +361,476 $0.000000 361,476 15 Jul 2022 Common Stock 361,476 $2.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares vest on the date of grant and on each of September 8, 2022, December 8, 2022 and March 8, 2023.
F2 240,984 shares vest on the date of grant and 120,492 shares vest on January 13, 2023.